Boxer Capital, LLC Fulcrum Therapeutics, Inc. Transaction History

Boxer Capital, LLC

  • $1.88 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$14.0 - $28.44 $17.5 Million - $35.6 Million
-1,250,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.28 - $30.97 $9.1 Million - $38.7 Million
1,250,000 New
1,250,000 $35.3 Million
Q4 2020

Feb 16, 2021
SELL
$7.84 - $13.4 $5.53 Million - $9.46 Million
-705,882 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$9.11 - $22.06 $6.43 Million - $15.6 Million
705,882 New
705,882 $12.9 Million

Others Institutions Holding FULC

# of Institutions
150
Shares Held
52.2M
Call Options Held
6.91M
Put Options Held
1.9M
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $237M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email